![Evis Sala](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Evis Sala was the founder of Lucida Medical Ltd.
and held the title of Chief Medical Officer.
Cargos activos de Evis Sala
Empresas | Cargo | Inicio |
---|---|---|
Lucida Medical Ltd.
![]() Lucida Medical Ltd. Medical SpecialtiesHealth Technology Lucida Medical Ltd. is a start-up based in Cambridge, UK that develops AI-based technology to assist clinicians in finding cancer more accurately, diagnosing and treating it more effectively, and saving time. The company was founded in 2019 by Dr. Antony Rix, an expert in medical devices, machine learning, and AI, and Prof. Evis Sala, who was a professor of oncological imaging at the University of Cambridge & Addenbrookes Hospital at the time. Lucida Medical's first product, Prostate Intelligence™ (PI™), is intended for use to assist in the diagnosis of prostate cancer and has completed regulatory approvals. The British company enables healthcare professionals to find cancer quickly and efficiently with artificial intelligence (AI) and magnetic resonance imaging (MRI). Antony William Rix has been the CEO since incorporation. | Fundador | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Lucida Medical Ltd.
![]() Lucida Medical Ltd. Medical SpecialtiesHealth Technology Lucida Medical Ltd. is a start-up based in Cambridge, UK that develops AI-based technology to assist clinicians in finding cancer more accurately, diagnosing and treating it more effectively, and saving time. The company was founded in 2019 by Dr. Antony Rix, an expert in medical devices, machine learning, and AI, and Prof. Evis Sala, who was a professor of oncological imaging at the University of Cambridge & Addenbrookes Hospital at the time. Lucida Medical's first product, Prostate Intelligence™ (PI™), is intended for use to assist in the diagnosis of prostate cancer and has completed regulatory approvals. The British company enables healthcare professionals to find cancer quickly and efficiently with artificial intelligence (AI) and magnetic resonance imaging (MRI). Antony William Rix has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Evis Sala